YouTube as a platform to better understand the treatment of lymphoma using ibrutinib: a cross-sectional study.

ABSTRACT:

Background

Ibrutinib, one Food and Drug Administration-approved, orally available, small-molecule Bruton tyrosine kinase (BTK) inhibitor, is an effective targeted therapy for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). YouTube is increasingly used for health purposes. However, videos for ibrutinib on YouTube have not been previously evaluated. This study assessed the accuracy and quality of YouTube videos on ibrutinib, to better understand the information shown on a dominant media platform.

Methods

The first 150 video results returned by the YouTube search engine in response to the keyword "ibrutinib" were included (up to June 27, 2022). Typically used predefined inclusion and exclusion criteria were applied to screen the videos based on

SUBMITTER: Yang L 

PROVIDER: S-EPMC9469172 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature